Pliant Therapeutics PLRX
NASDAQ PLRX
$0.77 -0.02 (-1.99%)
As of: Nov 11, 2026 · 1:23 PM EST

Pliant Therapeutics (PLRX) Price to FCF (2020)

Updated

Pliant Therapeutics' (PLRX) Price to FCF came in at 54.17 for Q3 2020, up 118.2% from the prior quarter.

Analysis

Pliant Therapeutics (PLRX) Price to FCF (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Pliant Therapeutics 48.92 Mn -712.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 54.17
Jun 30, 2020 24.83
API Access

Pliant Therapeutics Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=PLRX&period=max&api_key=YOUR_API_KEY